Terms: = Breast cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
396 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against breast cancer: In vitro and In silico Analysis.
Gupta K; Gautre P; Biharee A; Singh Y; Patil UK; Kumar S; Thareja S
Med Oncol; 2024 Feb; 41(4):81. PubMed ID: 38400892
[TBL] [Abstract] [Full Text] [Related]
3. Biological basis of extensive pleiotropy between blood traits and cancer risk.
Pardo-Cea MA; Farré X; Esteve A; Palade J; Espín R; Mateo F; Alsop E; Alorda M; Blay N; Baiges A; Shabbir A; Comellas F; Gómez A; Arnan M; Teulé A; Salinas M; Berrocal L; Brunet J; Rofes P; Lázaro C; Conesa M; Rojas JJ; Velten L; Fendler W; Smyczynska U; Chowdhury D; Zeng Y; He HH; Li R; Van Keuren-Jensen K; de Cid R; Pujana MA
Genome Med; 2024 Feb; 16(1):21. PubMed ID: 38308367
[TBL] [Abstract] [Full Text] [Related]
4. The dual activity of CaONPs as a cancer treatment substance and at the same time resistance to harmful microbes.
Awaad A; Olama ZA; El-Subruiti GM; Ali SM
Sci Rep; 2023 Dec; 13(1):22940. PubMed ID: 38135693
[TBL] [Abstract] [Full Text] [Related]
5. Longitudinal trajectory of amplitude of low-frequency fluctuation changes in breast cancer patients during neoadjuvant chemotherapy-A preliminary prospective study.
Hu Y; Yu H; Lai Y; Liu J; Tan Y; Lei W; Zhang J; Zhou X; Cao Y; Tang Y; Liu D; Zhang J
Brain Res Bull; 2024 Jan; 206():110845. PubMed ID: 38101650
[TBL] [Abstract] [Full Text] [Related]
6. Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?
Waitzberg ÂFL; Ferreira ENE; Pinilla M; Pineda P; Malinverni ACM; Soares FA; Carraro DM
Acta Cir Bras; 2023; 38():e386823. PubMed ID: 38055384
[TBL] [Abstract] [Full Text] [Related]
7. The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
Toda S; Iwasaki H; Okubo Y; Hayashi H; Kadoya M; Takahashi H; Yokose T; Hiroshima Y; Masudo K
Endocr J; 2024 Jan; 71(1):31-37. PubMed ID: 38044137
[TBL] [Abstract] [Full Text] [Related]
8. Substitution Kinetics, Albumin and Transferrin Affinities, and Hypoxia All Affect the Biological Activities of Anticancer Vanadium(V) Complexes.
Levina A; Uslan C; Murakami H; Crans DC; Lay PA
Inorg Chem; 2023 Oct; 62(43):17804-17817. PubMed ID: 37858311
[TBL] [Abstract] [Full Text] [Related]
9. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract] [Full Text] [Related]
10. Mechanisms of breast cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
12. Suppression of migration and invasion by taraxerol in the triple-negative breast cancer cell line MDA-MB-231 via the ERK/Slug axis.
Xia YT; Zhang YQ; Chen L; Min L; Huang D; Zhang Y; Li C; Li ZH
PLoS One; 2023; 18(9):e0291693. PubMed ID: 37751436
[TBL] [Abstract] [Full Text] [Related]
13. Malignant phyllodes tumour with lymph node metastasis: a diagnostic conundrum resolved by next generation DNA sequencing.
Schwartz CJ; Krings G; Chen YY
Histopathology; 2024 Jan; 84(2):409-411. PubMed ID: 37706238
[TBL] [Abstract] [Full Text] [Related]
14.
Jensen MR; Jelsig AM; Gerdes AM; Hölmich LR; Kainu KH; Lorentzen HF; Hansen MH; Bak M; Johansson PA; Hayward NK; Van Overeem Hansen T; Wadt KAW
HGG Adv; 2023 Oct; 4(4):100225. PubMed ID: 37646013
[No Abstract] [Full Text] [Related]
15. Regulation and clinical potential of telomerase reverse transcriptase (tert/htert) in breast cancer.
Yang R; Han Y; Guan X; Hong Y; Meng J; Ding S; Long Q; Yi W
Cell Commun Signal; 2023 Aug; 21(1):218. PubMed ID: 37612721
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value and immune landscapes of tert promoter methylation in triple negative breast cancer.
Lin F; Huang J; Zhu W; Jiang T; Guo J; Xia W; Chen M; Guo L; Deng W; Lin H
Front Immunol; 2023; 14():1218987. PubMed ID: 37575241
[TBL] [Abstract] [Full Text] [Related]
17. 5hmC Immunohistochemistry: A Predictor of
Hysek M; Hellgren SL; Condello V; Xu Y; Larsson C; Zedenius J; Juhlin CC
J Histochem Cytochem; 2023 Aug; 71(8):451-458. PubMed ID: 37486076
[TBL] [Abstract] [Full Text] [Related]
18. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory breast cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract] [Full Text] [Related]
19. Mutational profiling of Chinese patients with thyroid cancer.
Du Y; Zhang S; Zhang G; Hu J; Zhao L; Xiong Y; Shen L; Chen R; Ye K; Xu Y
Front Endocrinol (Lausanne); 2023; 14():1156999. PubMed ID: 37465126
[TBL] [Abstract] [Full Text] [Related]
20. Phthalocyanine-Blue Nanoparticles for the Direct Visualization of Tumors with White Light Illumination.
Amirshaghaghi A; Chang WC; Chhay B; Bartolomeu AR; Clapper ML; Cheng Z; Tsourkas A
ACS Appl Mater Interfaces; 2023 Jul; 15(28):33373-33381. PubMed ID: 37395349
[TBL] [Abstract] [Full Text] [Related]
[Next]
